News

Obesity Clinical Trials Appears Robust With 80+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
In June 2025, Carmot Therapeutics Inc. announced a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of ...
Uveitis Treatment Market Size In The 7MM Was ~USD 1,468.66 Million In 2022 And Is Expected To Increase By 2034, Estimates Delveinsight
In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...